Inventor · disambiguated record
Kevin Clairmont
Also filed as: CLAIRMONT KEVIN · CLAIRMONT KEVIN B
10 granted patents·4 pending applications·102 citations·filing 1995–2022
87Inventor score
Files withBAYER PHARMACEUTICALS CORP9BARNES DAVID WENINGER2BAYER AG1BAYER HEALTHCARE LLC1NOVARTIS AG1
Top patents by PatentIndex Score
14 records- 0194US7041646B2Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonistsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted May 9, 2006·43 cites·3 claims
- 0292US6864069B2Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of useBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Mar 8, 2005·34 cites·3 claims
- 0375US8697739B2Bicyclic acetyl-CoA carboxylase inhibitors and uses thereofBARNES DAVID WENINGER·Filed 2011·Granted Apr 15, 2014·4 cites·23 claims
- 0461US7399745B2Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of useBAYER HEALTHCARE LLC·Filed 2004·Granted Jul 15, 2008·0 cites·4 claims
- 0560US7494978B2Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of useBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Feb 24, 2009·0 cites·11 claims
- 0660US7488714B2Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of useBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Feb 10, 2009·0 cites·9 claims
- 0760US7488716B2Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of useBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Feb 10, 2009·0 cites·11 claims
- 0860US7488715B2Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of useBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Feb 10, 2009·0 cites·11 claims
- 0960US5972680AGlucose transporter vesicle aminopeptidaseBAYER AG·Filed 1995·Granted Oct 26, 1999·21 cites·6 claims
- 1060US2006003935A1Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of useBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 1155US2024309084A1Degradation of extracellular targetsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1248US9789118B2Bicyclic acetyl-CoA carboxylase inhibitors and uses thereofBARNES DAVID WENINGER·Filed 2014·Granted Oct 17, 2017·0 cites·20 claims
- 1343US2009280106A1Pituitary adenylate cyclase acivating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of useBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 1440US2009143283A1Pituitary Adenylate Cyclase Activating Peptide (PACAP) Receptor (VPAC2) Agonists and Their Pharmacological Methods of UseBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin Clairmont files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →